vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and NATIONAL BANKSHARES INC (NKSH). Click either name above to swap in a different company.
NATIONAL BANKSHARES INC is the larger business by last-quarter revenue ($15.3M vs $9.2M, roughly 1.7× Foghorn Therapeutics Inc.). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -234.3%, a 272.8% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 24.7%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 20.9%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
FHTX vs NKSH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $15.3M |
| Net Profit | $-21.7M | $5.9M |
| Gross Margin | — | — |
| Operating Margin | -258.2% | 47.4% |
| Net Margin | -234.3% | 38.5% |
| Revenue YoY | 223.8% | 24.7% |
| Net Profit YoY | -11.1% | 91.0% |
| EPS (diluted) | $-0.35 | $0.93 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $15.3M | ||
| Q3 25 | $8.2M | $14.2M | ||
| Q2 25 | $7.6M | $13.3M | ||
| Q1 25 | $6.0M | $12.8M | ||
| Q4 24 | $2.9M | $12.2M | ||
| Q3 24 | $7.8M | $11.7M | ||
| Q2 24 | $6.9M | $10.9M | ||
| Q1 24 | $5.0M | $10.4M |
| Q4 25 | $-21.7M | $5.9M | ||
| Q3 25 | $-15.8M | $4.4M | ||
| Q2 25 | $-17.9M | $2.3M | ||
| Q1 25 | $-18.8M | $3.2M | ||
| Q4 24 | $-19.5M | $3.1M | ||
| Q3 24 | $-19.1M | $2.7M | ||
| Q2 24 | $-23.0M | $-307.0K | ||
| Q1 24 | $-25.0M | $2.2M |
| Q4 25 | -258.2% | 47.4% | ||
| Q3 25 | -226.9% | 37.9% | ||
| Q2 25 | -279.2% | 20.0% | ||
| Q1 25 | -385.0% | 30.5% | ||
| Q4 24 | -840.5% | 30.1% | ||
| Q3 24 | -305.5% | 27.5% | ||
| Q2 24 | -386.6% | -4.4% | ||
| Q1 24 | -558.3% | 25.8% |
| Q4 25 | -234.3% | 38.5% | ||
| Q3 25 | -194.4% | 31.1% | ||
| Q2 25 | -237.3% | 17.2% | ||
| Q1 25 | -316.4% | 25.3% | ||
| Q4 24 | -682.9% | 25.1% | ||
| Q3 24 | -244.9% | 22.8% | ||
| Q2 24 | -333.6% | -2.8% | ||
| Q1 24 | -495.4% | 20.8% |
| Q4 25 | $-0.35 | $0.93 | ||
| Q3 25 | $-0.25 | $0.69 | ||
| Q2 25 | $-0.28 | $0.36 | ||
| Q1 25 | $-0.30 | $0.51 | ||
| Q4 24 | $-0.23 | $0.50 | ||
| Q3 24 | $-0.31 | $0.42 | ||
| Q2 24 | $-0.45 | $-0.05 | ||
| Q1 24 | $-0.59 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $59.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $184.9M |
| Total Assets | $198.1M | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $59.3M | ||
| Q3 25 | $89.3M | $42.3M | ||
| Q2 25 | $72.6M | $92.8M | ||
| Q1 25 | $61.0M | $122.5M | ||
| Q4 24 | $55.5M | $108.1M | ||
| Q3 24 | $57.7M | $49.8M | ||
| Q2 24 | $138.9M | $98.9M | ||
| Q1 24 | $79.3M | $121.2M |
| Q4 25 | $-108.5M | $184.9M | ||
| Q3 25 | $-89.7M | $179.2M | ||
| Q2 25 | $-76.7M | $168.7M | ||
| Q1 25 | $-61.7M | $167.3M | ||
| Q4 24 | $-45.5M | $156.4M | ||
| Q3 24 | $-28.3M | $167.8M | ||
| Q2 24 | $-14.3M | $149.0M | ||
| Q1 24 | $-97.5M | $139.4M |
| Q4 25 | $198.1M | $1.8B | ||
| Q3 25 | $205.0M | $1.8B | ||
| Q2 25 | $226.2M | $1.8B | ||
| Q1 25 | $258.7M | $1.8B | ||
| Q4 24 | $284.0M | $1.8B | ||
| Q3 24 | $308.4M | $1.8B | ||
| Q2 24 | $328.6M | $1.8B | ||
| Q1 24 | $255.0M | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $17.9M |
| Free Cash FlowOCF − Capex | — | $15.2M |
| FCF MarginFCF / Revenue | — | 99.2% |
| Capex IntensityCapex / Revenue | 0.0% | 17.9% |
| Cash ConversionOCF / Net Profit | — | 3.04× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $17.9M | ||
| Q3 25 | $-18.9M | $6.1M | ||
| Q2 25 | $-21.0M | $2.1M | ||
| Q1 25 | $-24.0M | $2.6M | ||
| Q4 24 | $-24.5M | $9.4M | ||
| Q3 24 | $-21.0M | $3.1M | ||
| Q2 24 | $-25.5M | $-3.0M | ||
| Q1 24 | $-29.3M | $3.8M |
| Q4 25 | — | $15.2M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | $-21.0M | $1.5M | ||
| Q1 25 | $-24.0M | $1.6M | ||
| Q4 24 | $-25.0M | $6.2M | ||
| Q3 24 | $-21.3M | $2.2M | ||
| Q2 24 | $-25.6M | $-4.0M | ||
| Q1 24 | $-29.4M | $3.5M |
| Q4 25 | — | 99.2% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | -278.2% | 11.5% | ||
| Q1 25 | -403.2% | 12.5% | ||
| Q4 24 | -875.3% | 50.5% | ||
| Q3 24 | -273.0% | 18.5% | ||
| Q2 24 | -371.0% | -36.3% | ||
| Q1 24 | -583.1% | 33.8% |
| Q4 25 | 0.0% | 17.9% | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | 0.3% | 4.1% | ||
| Q1 25 | 0.5% | 7.5% | ||
| Q4 24 | 16.8% | 26.6% | ||
| Q3 24 | 4.0% | 8.3% | ||
| Q2 24 | 0.2% | 9.3% | ||
| Q1 24 | 2.0% | 3.0% |
| Q4 25 | — | 3.04× | ||
| Q3 25 | — | 1.38× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.79× | ||
| Q4 24 | — | 3.07× | ||
| Q3 24 | — | 1.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
